Published Date: 02 Mar 2023
Although it is recognized that pain is common among nursing home residents, little attention has been paid to how this pain changes over time. A new study from the Regenstrief Institute and the Indiana University School of Nursing...
Read Full NewsThe FDA is requiring new labeling across all GLP-1 receptor agonists to warn of a potential increased risk of a rare, vision-threatening optic nerve condition.
David Leehey, MD, says about half of the 2376 enrolled veterans were taking an SGLT2 inhibitor at baseline.
1.
Higher Risk of Kidney Cancer Recurrence After Ablative Therapy
2.
Breast Cancer Incidence Rises in Asian American Women
3.
Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival
4.
Can patients receiving immunotherapy for cancer benefit from taking vitamin D supplements?
5.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
1.
Multispecific Immune Engagers: Engineering T Cells, NK Cells and Tumor Recognition Beyond Bispecific Antibodies
2.
Unlocking the Secrets of Improved Ovarian Cancer Survival Rates
3.
Therapeutic Advances in Cancer-Associated Fibroblast Reprogramming
4.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
5.
Drug Exposure During Cytopenia: Clinical Considerations and Evidence-Based Management
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part II
5.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation